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ApoptosisDNA damage, which perturbs genomic stability, has been linked to cognitive decline in the aging human brain,
and mutations in DNA repair genes have neurological implications. Several studies have suggested that DNA
damage is also increased in brain disorders such as Alzheimer's disease, Parkinson's disease and amyotrophic
lateral sclerosis. However, the precise mechanisms connecting DNA damage with neurodegeneration remain
poorly understood. CDK5, a critical enzyme in the development of the central nervous system, phosphorylates
a number of synaptic proteins and regulates dendritic spine morphogenesis, synaptic plasticity and learning. In
addition to these physiological roles, CDK5 has been involved in the neuronal death initiated by DNA damage.
We hypothesized that p19INK4d, a member of the cell cycle inhibitor family INK4, is involved in a neuroprotec-
tivemechanismactivated in response toDNAdamage.We found that in response to genotoxic injury or increased
levels of intracellular calcium, p19INK4d is transcriptionally induced and phosphorylated by CDK5 which
provides it with greater stability in postmitotic neurons. p19INK4d expression improves DNA repair, decreases
apoptosis and increases neuronal survival under conditions of genotoxic stress. Our in vivo experiments showed
that decreased levels of p19INK4d rendered hippocampal neuronsmore sensitive to genotoxic insult resulting in
the loss of cognitive abilities that rely on the integrity of this brain structure. We propose a feedbackmechanism
by which the neurotoxic effects of CDK5-p25 activated by genotoxic stress or abnormal intracellular calcium
levels are counteracted by the induction and stabilization of p19INK4d protein reducing the adverse conse-
quences on brain functions.
© 2014 Elsevier B.V. All rights reserved.1. Introduction
Neuronal apoptosis is an essential process in the development of the
nervous system especially during synaptogenesis. Through develop-
ment, the nervous system is generated with an excess number of
neurons. This production in excess is followed by apoptosis during a
restricted developmental period, leading to the elimination of as much
as half of the originally produced cells [1–3]. This massive apoptosis is
crucial to shaping the complex architecture of the brain and establish
the neuronal circuits needed for the execution of motor function,yclin-dependent kinase; ODN,
active oxygen species; UDS,
Biológica, Facultad de Ciencias
iso 4, 1428 Ciudad de Buenos
.learning and memory among other tasks. It is supposed that only
those neurons that receive the proper trophic input from their targets
will survive [4–6].
In addition to the extensive naturally occurring cell death in the
developing nervous system, neuronal apoptosis is a prominent feature
in a number of acute and chronic neurological diseases including stroke,
Alzheimer's disease, and amyotrophic lateral sclerosis [7,8]. In general,
neuronal apoptosis in these disorders seems not to be the result of
trophic factor withdrawal, but of toxic insults such as abnormal protein
aggregates and free-radical generation.
DNAdamagemay also be engaged in numerous conditions involving
neuronal death. The nervous system is very sensitive to DNA damage,
particularly in comparison with other tissues that contain non-
replicating cell types. There are some unique properties of the nervous
system that may account for this relative sensitivity. The brain metabo-
lizes ~20% of the oxygen consumed but has lower ability than other
body parts to neutralize reactive oxygen species (ROS) and neurons
are particularly susceptible to oxidative stress. This high oxidative load
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[9,10].
Evidence suggests that DNA damage may be a central event in
neurodegeneration [11]. For instance, DNA strand breaks occur as an
early event after reperfusion of the ischemic brain, and DNA lesions
have been reported in Parkinson's and Alzheimer's diseases [12,13].
Furthermore, congenital syndromes with DNA repair gene mutations,
such as ataxia telangiectasia andWerner's syndrome, display a progres-
sive neurodegeneration phenotype [11]. In addition, DNA damage is
involved in the aging of the human brain, which suggests that DNA
damage may play a role in age-dependent neurodegenerative diseases
as well [14,15]. These observations demonstrate the importance of
maintaining DNA integrity in the mature brain.
Cyclin-dependent kinase 5 (CDK5) is a member of the cyclin-
dependent kinase family of serine/threonine kinases that is critical for
the development of the central nervous system. CDK5 is expressed
ubiquitously inmany tissues; however, its activity is restricted primarily
to the nervous system due to neuron-speciﬁc expression of its activator
molecules p35 and p39 [16,17]. CDK5 phosphorylates a number of
synaptic proteins and regulates dendritic spine morphogenesis,
synaptic plasticity and learning [18]. Nevertheless, in addition to these
physiological roles, CDK5 also has a dark side [19]. Evidence suggests
that CDK5 becomes an inducer of death when its activator p35 is
cleaved into a smaller p25 form by calpains and may play a role in the
pathogenesis of neurodegenerative disorders, such as Alzheimer's
disease and amyotrophic lateral sclerosis [20]. Accumulation of p25
and involvement of CDK5 have been observed in neurons treated with
excitotoxins, β-amyloid, and oxidative stress, as well as in animal
models of stroke and Parkinson's disease [21]. In these conditions,
calpain-directed proteolysis of p35 deprives the membrane-associated
p35 of an N-terminal myristoylated membrane tether, releasing p25
into the cytoplasm. More recently, CDK5 has been involved in neuronal
death initiated by DNA damage [22].
Recentworks have reported that p16INK4a andp19INK4d (hereafter
referred to as p19), two proteins from the INK4 family, could be
involved in the cellular response to genotoxic agents [23–25]. In partic-
ular, there are strong evidences that p19 plays a crucial role in regulating
genomic stability and cell viability. Notably, improvement of DNA repair
in cells that overexpress p19 inversely correlates with the apoptosis
triggered by DNA damage [26]. These results suggest that, in addition
to its role in improving DNA repair, p19 negatively modulates DNA
damage-induced apoptosis in mammalian cells. On this matter, recent
studies performed in p19 null mice have demonstrated that the absence
of p19 renders cells sensitive to apoptotic and autophagic cell death
[27].
INK4 family members are differentially expressed during develop-
ment [28]. p19 is expressed at high levels within the central nervous
system from embryonic day 11.5 onward. During the development of
the neocortex asymmetric division gives rise to differentiated neurons
that express p19, expression that continues in postmitotic neurons
and the adult brain, including the hippocampus, cortex, cerebellum
and brainstem [29,30]. The described ability of p19 tomaintain genomic
integrity and its sustained expression in neurons allowus to hypothesize
that this protein is involved in a neuroprotective mechanism activated
in response to genotoxic damage.
In the present studywe demonstrated that, in response to genotoxic
damage or increased levels of intracellular calcium, p19 is induced and
phosphorylated in differentiated human neuroblastoma SH-SY5Y cells
and in the primary cultures of neurons from rat hippocampus.
Genotoxic stress increases CDK5 activity, which, in turn, phosphorylates
p19 protein providing it with greater stability. We demonstrated that
p19 improves DNA repair, decreases apoptosis and increases neuronal
survival under conditions of genotoxic stress. Our in vivo experiments
showed that decreased levels of p19 rendered hippocampal neurons
that are more sensitive to genotoxic insult resulting in the loss of the
cognitive abilities rely on the integrity of this neural structure. Theresults presented herein describe a mechanism by which p19 protein
participates in the maintenance of genomic integrity in neuronal cells.
2. Materials and methods
2.1. Cell cultures and experimental treatments
The human neuroblastoma cell line SH-SY5Y (ATCC, CRL-2266) was
grown inDulbecco'smodiﬁed Eaglemedium (45%) andHAMF-12 (45%)
(DMEM/F12; Invitrogen) supplemented with 10% fetal bovine serum
(FBS), 1% penicillin/streptomycin, 2 mM glutamine and 1 mM sodium
pyruvate (Invitrogen) at 37 °C in a humidiﬁed 5% CO2 atmosphere.
The mouse neuroblastoma Neuro-2a (ATCC, CCL-131) and the human
embryonic kidney HEK293 (ATCC, CRL-1537) cell lines were main-
tained in Dulbecco'smodiﬁed Eaglemedium and similarly supplement-
ed. SH-SY5Y cells were differentiated to a neuronal phenotype by
growth in DMEM/F12 with 0.2% FBS plus 1 μM ATRA for 7 days.
Primary hippocampal cell cultures were established from E18–E19
embryos aseptically removed from pregnant Wistar rats. Dissociated
cultures of hippocampal pyramidal cells from embryonic rat brain tissue
were then prepared as described previously [31]. Brieﬂy, hippocampi
were treated with trypsin (0.25% for 15 min at 37 °C), washed with a
Ca- and Mg-free Hank's balanced solution, and dissociated by repeated
passages through a constricted Pasteur pipette. The nerve cell suspen-
sions were then plated on culture dishes coated with poly-D-lysine
(1 μg/ml; Sigma-Aldrich). After plating, the cells were incubated for
2–3 h in DMEM containing 10% FBS to enable the neurons to attach to
the substrate. The medium was replaced with NeurobasalTM medium
(GIBCO) containing 1% N2 and 2% B27 serum-free supplements
(GIBCO), and the cultures were maintained in a humidiﬁed 37 °C incu-
bator with 5% CO2.
β-Amyloid peptide (amyloid β-protein fragment 25–35, Sigma)was
added in a ﬁnal concentration of 10 μM for the indicated period of time.
NCS (Sigma-Aldrich) was added in a ﬁnal concentration of 100 ng/ml
(unless otherwise indicated) for the indicated period of time.
Camptothecinwas used in aﬁnal concentration of 1 μMfor the indicated
period of time. UVC lightwasused in some cases to induce DNAdamage.
Cells were irradiated in open-dishes with the corresponding 40 J/m2
UVCdose, 254 nm(range 240–280nm) at room temperature. Following
UV-irradiation, the medium was replaced and cells were incubated for
the indicated time at 37 °C in a 5% CO2 humidiﬁed incubator along the
times indicated in each case.
Antisense oligodeoxynucleotides at a ﬁnal concentration of 1 μM
were used to selectively knock down the expression of different
mRNA genes as indicated. All the sequences are described in the
Supporting information.
2.2. Cell transfection
Transient transfections were performed with Lipofectamine™ 2000
reagent (Invitrogen) following the manufacturer's protocol. Before
transfection 1 × 106 cells were seeded in 60-mm dishes. Six μg of total
DNA and/or pBabePuro (0.5 μg) and Lipofectamine™ 2000 (4 μl) were
used per dish. Twenty-four hours after transfection, selection was
carried on with 1 μg/ml puromycin for 48 h. All the plasmids used are
described in the Supporting information.
For the establishment of stable clones, the pMTCB6 vector, contain-
ing aNotI–BamHI fragment encoding thehumanp19 cDNAdownstream
themetallothionein promoter carrying a selectable neomycin-resistance
gene (pMTp19S), was used. The pMTp19ASwas constructed cloning the
p19 cDNA in the reverse orientation. Transfections were performed
using Lipofectamine™ 2000 Reagent (Invitrogen). Twenty-four hours
after the transfection cells were replated at low density to isolate single
colonies. The clonal cell lines SH-SY5Y empty, SH-SY5Yp19S, SH-
SY5Yp19AS, from now on, derived from the transfectants were main-
tained in selective medium containing 4 mg/ml geneticin disulfate
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induction stable transformants were treated with 100 μM ZnSO4 for at
least 16 h.
Hippocampal neurons were transfected with the antisense oligode-
oxynucleotide to p19 (p19AS) at a ﬁnal concentration of 400 nM
using FuGENE® HD Transfection Reagent (Roche) according to the
manufacturer's protocol.
2.3. RNA extraction and Northern blot analysis
RNA extraction and Northern blot analysis were previously
described [32]. Brieﬂy, 10–20 μg of total RNAwas denatured, electropho-
resed in 1% glyoxal–agarose gels, and transferred to nylon membranes
(Hybond N, Amersham). Membranes were sequentially hybridized
with the indicated [32P]-labeled probes and radioactivity was detected
using a PhosphorImager (FujiFilm BAS-1800II).
2.4. Western blot
Total cell lysates and Western blot analysis were carried out as
previously described [33]. The following antibodies were used: mouse
anti-p19INK4d (P0999-55A, US Biological), mouse anti-p19INK4d
(ZP002, Invitrogen), rabbit anti-p19INK4d (M-167, Santa Cruz Biotech-
nology), rabbit anti-CDK5 (C-8, Santa Cruz Biotechnology), rabbit anti-
CDK2 (M2, Santa Cruz Biotechnology), rabbit anti-p35 (C-19, Santa
Cruz Biotechnology),mouse anti-β-actin (C4, Santa Cruz Biotechnology),
mouse anti-V5 (R960-25, Invitrogen), rabbit anti-MAP2 (Cell Signaling
Technology), mouse anti-phospho-H2A.X (Ser139) (JBW301, Upstate),
mouse anti-phospho-ATM (Ser1981) (10H11.E12, Abcam), and rabbit
anti-ATM (Abcam). Anti-mouse and anti-rabbit secondary antibodies
conjugated with horseradish peroxidase were purchased from Sigma
(Saint Louis, USA).
2.5. Metabolic labeling and immunoprecipitation of phospho-p19
Differentiated SH-SY5Y cells were grown in 60-mm dishes. Cells
were incubated with 0.5 mCi [32P]-sodium orthophosphate for 3 h
prior to their treatment as indicated in each experiment. At different
time points after treatments, cells were washed, collected in cold PBS
and lysed in RIPA buffer. The lysates (100 μg)were incubatedwith poly-
clonal rabbit p19 antibody (M-167, Santa Cruz Biotechnology) for 2 h,
followed by an overnight incubation with protein A/G agarose beads
(Santa Cruz Biotechnology) at 4 °C. After washing three times with
PBS, samples were analyzed by SDS-PAGE. Dried gels were exposed to
a radiographic intensifying screen by Fujiﬁlm and scanned directly
using a Bio-Imaging Analyzer Fujiﬁlm BAS-1800II.
2.6. CDK5 in vitro kinase assay
In vitro kinase assay was performed as described before [34]. Brieﬂy,
differentiated SH-SY5Y cells were washed with PBS and lysed in HB
buffer (25 mMMOPS pH 7.2, 15 mM EGTA, 15 mMMgCl2, 1 mM DTT,
1% Tritón-X 100, 0.5 mM NaF, 0.1 mM sodium orthovanadate, 1 mM
PMSF, 1× protease inhibitor cocktail). Proteins (0.5 mg) were immuno-
precipitated with 1 μg of anti-CDK5 antibody (C-8, sc-173, Santa Cruz
Biotechnology) and 20 μl of 50% slurry of protein A/G-agarose beads
(Sigma) and rocked at 4 °C for 2 h. For the control sample containing
only the substrate (histone H1 derived peptide, p-H1, PKTPKKAKKL)
but no enzyme, proteins were incubated with the beads without anti-
CDK5 antibody. The beads were washed and resuspended in a 15 μl
HB buffer. Each sample was added 15 μl of 2× kinase reaction buffer
(HB buffer containing 200 μM ATP, 200 μM p-H1 and 1 μl of [γ-32P]
ATP (6000 Ci/mmol [10 μCi/μl]) per 10 μl of 2× reaction buffer). Sam-
pleswere incubated for 30min at 37 °C. Following the reaction, samples
were processed according to the phosphocellulose paper method. As a
negative control, the reaction was conducted without substrate. In asimilar assay, phosphorylation of a p19 derived peptide containing the
surrounding sequence of S76 (p-S76; RGTSPVHDAART; 200 mM) was
tested. As control for CDK5 activity, the histone H1 derived peptide
was used. As a negative control, the reaction was conducted without
substrate (none).
To evaluate thedirect phosphorylation of p19 by CDK5, differentiated
SH-SY5Y cells were lysed in HB buffer. Proteins (1 mg) were immuno-
precipitated with 2 μg of anti-CDK5 antibody and 50 μl of 50% slurry of
protein A/G-agarose beads (SIGMA) and rocked at 4 °C for 2 h. For the
control sample containing only the substrate (GST-p19) but no enzyme,
proteins were incubated with the beads without anti-CDK5 antibody.
The beadswerewashed and resuspended in a 15 μl HBbuffer. Each sam-
ple was added 15 μl of 2× kinase reaction buffer (HB buffer containing
200 μM ATP, 1 mg/ml GST-p19, and 1 μl of [γ-32P]ATP (6,000 Ci/mmol
[10 μCi/μl]) per 10 μl of 2× reaction buffer). Samples were incubated
for 20 min at 37 °C. The reaction was stopped by an addition of 7.5 μl
of 5× sample buffer and 5 min incubation at 95 °C. Histone H1 from
calf thymus (Calbiochem) was used for kinase activity control. Samples
were electrophoresed on 12% denaturing gels. Gels were dried on
Whatman paper, exposed to a radiographic intensifying screen by
Fujiﬁlm and scanned directly using a Bio-Imaging Analyzer Fujiﬁlm
BAS-1800II.
2.7. Unscheduled DNA synthesis
SH-SY5Yempty, SH-SY5Yp19S and SH-SY5Yp19AS cells were seeded
at 1 × 106 cells per 35-mm plate and treated with 1 μM ATRA during
6 days. After differentiation, cellswere incubatedwith a culturemedium
containing 0.5% fetal bovine serum and 100 μM ZnSO4. We determined
that under these conditions, DNA semi-conservative synthesis was
completely inhibited. After 16 h, the medium was changed to a fresh
medium containing 1% fetal calf serum and incubated with 10 μM
β-amyloid peptide or 100 ng/ml NCS and 10 μCi/ml [3H]-thymidine.
Hippocampal neurons were seeded at 5 × 105 cells per 35-mm plate.
After 2 days, neurons were transfected with p19 antisense oligonucleo-
tide and, 24 h later, incubated with 10 μM β-amyloid peptide or
50 ng/ml NCS and 10 μCi/ml [3H]-thymidine. At the indicated times,
SH-SY5Y or neuron cells were washed three times with cold PBS,
harvested and pelleted at 3000 ×g for 5 min. The cells were lysed
with 5% TCA for 30 min and centrifuged at 10000 ×g for 10 min.
The pellet was washed twice with cold PBS and resuspended in 1 M
NaOH. The incorporated radioactivity was quantiﬁed by scintillation
counting. Unscheduled DNA synthesis was estimated as dpm/μg of
protein.
2.8. Caspase-3 activity
SH-SY5Yempty, SH-SY5Yp19S and SH-SY5Yp19AS cells were seeded
at 1 × 106 cells per 35-mmplate and treated with 1 μMATRA during six
days. After differentiation, cells were incubated with 100 μM ZnSO4 for
16 h and, then, incubated with 10 μM β-amyloid peptide or 100 ng/ml
NCS. Hippocampal neurons were seeded at 5 × 105 cells per 35-mm
plate. After 2 days, neurons were transfected with p19 antisense oligo-
nucleotide and, 24 h later, incubated with 10 μM β-amyloid peptide or
100 ng/ml NCS. Twenty-four hours after genotoxic treatment caspase-
3 activity was determined as previously described [34]. Caspase activity
was estimated at A405/μg protein.
2.9. Cell viability assay
Cell viability was assessed by 3-[4,5-dimethylthiazol-2-yl]-2,5-
diphenyltetrazolium bromide (MTT) assay. Exponentially growing SH-
SY5Yp19S or SH-SY5Yp19AS cell lines (1 × 105 cells/well) were seeded
in 24-well plates and incubated with 100 μMZnSO4 for 16 h. Then, cells
were incubated with 50 ng/ml NCS. At the indicated times, the culture
media were replaced by 1 ml of fresh medium containing MTT
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After 4 h incubation, the medium and MTT were removed and 500 μl
of isopropanol was added. Plates were shaken for 15 min and the
absorbance in the solvent was determined at 570 nm. The background
was subtracted by using a dual-wavelength setting of 570 and650 nm. Control included untreated cells and medium alone. Hippo-
campal neurons (4 × 104 cells/well) were seeded in 96-well plates.
After two days, neurons were transfected with p19 antisense oligonu-
cleotide and, 24 h later, incubated with 10 μM β-amyloid peptide or
50 ng/ml NCS and cell viability was determined as described above.
1313M.F. Ogara et al. / Biochimica et Biophysica Acta 1843 (2014) 1309–13242.10. Clonogenic assay
Survival after NCS treatmentwas determined by clonogenic assay in
SH-SY5Yp19AS clonal cells. Cells were plated as single cell and treated
with different doses of NCS after metallothionein promoter induction
with 100 μM ZnSO4 for 16 h. Cells were incubated for 15 days followed
by ﬁxation with 10% formaldehyde, staining by the addition of crystal
violet (5 mg/ml in ethanol) and surviving clones counted. Colonies
containing N50 cells were rated as deriving from viable, clonogenically
capable cells.
2.11. Animals
Wistar female rats were provided by the Bioterio Central Facultad de
Ciencias Exactas y Naturales, University of Buenos Aires. C57BL/6J male
mice, 60–70 d of age, weighting 25–30 g, were used (La Plata University
Animal Facilities, La Plata, Argentina). The animals were individually
caged and singly housed throughout the experimental procedures,
with water and food ad libitum, under a 12 h light/dark cycle (lights
on at 8:00 A.M.) at temperature of 21–22 °C. Experiments were per-
formed in accordance with local regulations and the National Institutes
of Health (NIH) Guide of the Care and Use of Laboratory Animals (NIH
Publication 80-23/96) and were previously approved by the Ethical
Committee of the Facultad de Ciencias Exactas y Naturales, University
of Buenos Aires. All efforts were made to minimize animal suffering
and to reduce the number of animals used.
2.12. Surgery and injections
Micewere implanted under deep anesthesia (ketamine and xylazine)
with a 23-G guide cannula 1mmdorsally to the dorsal hippocampus, at
coordinates A −1.9, L ± 1.2, V 1.2 in accordance with the atlas of
Franklin and Paxinos [35]. Guide cannulae were ﬁxed to the skull with
dental acrylic. Experiments were performed following animal recovery
and injections were administered without anesthesia. The injection
device consisted of a 30-G cannula connected to a 5 μl Hamilton syringe
with tubing. Initially, the infusion device was ﬁlled with distilled water
and a small air bubble was sucked into the injection cannula, followed
by the injection solution. The air bubble allowed for a visual inspection
of the injection progress. The injection cannula was inserted into the
guide cannula with its tip extending beyond the guide by 1 mm in
order to reach the dorsal hippocampus. The injections were adminis-
tered during 30 s, and operated by hand. The injection cannula was
removed after 60 s in order to avoid reﬂux and to allow the diffusion
of drugs. The volume of each intrahippocampal infusion was 0.5 μl.
Different injection devices were used for drug and vehicle. Only data
from animals with cannulae located in the intended sites were included
in the analysis.Fig. 1. β-Amyloid peptide and neocarzinostatin treatments trigger the induction of mRNA p19
differentiated SH-SY5Y cells (right panel) were incubated with 10 μM β-amyloid peptide. Tota
analysiswith the 32P-labeled probes speciﬁed at the rightmargin. (B) Differentiated SH-SY5Y ce
At different timepoints, the expression of p19, p35 andCDK5were assessed byNorthernblot. (C
10 μM β-amyloid peptide (C) or 1 μM camptothecin (D). After 4 h (C) or at the indicated tim
(A–D) The ﬁgure shows a representative autoradiograph of three independent experiments w
lower panels. Bars represent the mean ± S.D. of three experiments. Student's t-test was us
(*p b 0.05; **p b 0.02; ***p b 0.01). (E) SH-SY5Y cells (left panel) and differentiated SH-SY5Y
were treated with 10 μM β-amyloid peptide for additional 4 h. Cells were harvested and sub
and reprobed for β-tubulinmRNA. The ﬁgure shows a representative autoradiograph of three in
in the lower panel. Bars represent themean± S.D. of three experiments. Student's t-test was u
(**p b 0.02). (F) Differentiated SH-SY5Y cells were transiently cotransfected with 4 μg p19CAT
250 nMwild-type or mutated E2F decoy, as indicated. After 24 h, cells were treated or not wit
and normalized to β-galactosidase activity. Results are expressed as relative CAT activity with
three independent experiments performed in quadruplicate. Student's t-test was used to an
were labeled with [32P]-orthophosphate and treated with 10 μM β-amyloid peptide (G) or 100
were subjected to immunoprecipitationwith anti-p19 antibody and the immune complexeswe
or immunoblotting (lower panels; p19). The ﬁgure shows a representative autoradiogra
neocarzinostatin (NCS), β-tubulin (β-tub), camptothecin (CPT), decoy E2F oligonucleotide (E2Fp19 antisense oligodeoxynucleotide (ODN) and its scrambled
sequence were injected at 1 nmol/μl in all antisense experiments.
Sequences: p19 antisense (p19ASODN: 5′-AGAAGCATAGTGGATACCGG-
3′) and p19 scrambled (ScrODN: 5′-ACAAGTTGGACACGGGAGAT-3′).
Vehicle: Hank's balanced salt solution (HBSS, pH 7.4). The antisense
for p19 mRNA was speciﬁc for the sequence that includes the transla-
tional start side. The respective ScrODN, which served as control,
contained the same base composition but in random order and show
no homology to sequences in the GenBank database. All oligonucleo-
tides were phosphorothiolated on the three terminal bases both 5′
and 3′ ends to produce increased stability [36]. NCS (Sigma-Aldrich)
was dissolved in HBSS and administrated at a ﬁnal concentration of
25 ng/ml, except for the dose–response curve (10, 25 and 100 ng/ml).
ODNs injections were done 16 h before NCS injection.
2.13. Immunohistochemistry
At the indicated times after NCS injections, mice were anesthetized
and perfused with 4% paraformaldehyde in PBS. Their brains were
postﬁxed overnight in the same ﬁxative with 30% sucrose. Sixty-
micrometer coronal sections were cut through the hippocampus in a
vibrating microtome. Sections were stored in a cryoprotectant solution
(25% glycerol, 25% ethylene glycol, 50% phosphate buffer 0.1 M
pH 7.4) at −20 °C until use. Immunohistochemistry technique was
performed on free-ﬂoating sections from 4 mice per group. Sections
were blocked for 1 h in PBS with 0.3% Triton X-100 and 5% goat serum
and incubated for 48 h at 4 °C in a clinical rotator with a mouse mono-
clonal anti-phospho-H2AX (Ser 139) antibody (1:200; JBW301,
Upstate) diluted in a blocking solution. After incubationwith secondary
ﬂuorescent antibody (anti-mouse Alexa 594, 1:1000; Invitrogen), sec-
tions were mounted with DAPI-Fluoromount-G (SouthernBiotech).
Slides were visualized using an Eclipse E600W Nikon microscope
and images were acquired with a Coolpix 5000 Nikon digital camera.
Quantiﬁcation of γH2AX-positive cells were performed using ImageJ
software (NIH).
2.14. Y-maze test
Working memory performance was assessed by recording continu-
ous alternation behavior during a single session in a Y-maze device.
The maze was made of transparent acrylic. Each arm was 40 cm long,
13 cm high, 3 cm wide at the bottom, 10 cm wide at the top, and
converging at an equal angle. Each mouse was placed at the end of one
arm and allowed to move freely through the maze during a 10-min
session. The series of arm entries was recorded using the ANY-maze
software via a cameramounted directly about themaze. A correct alter-
nation was deﬁned as entries into all three arms on consecutive occa-
sions. The number of maximum alternations was therefore the totaland the phosphorylation of its protein in neuronal cells. (A) SH-SY5Y cells (left panel) and
l RNA (10 μg) extracted from cells at the indicated times were subjected to Northern blot
lls were treatedwith 100 ng/ml neocarzinostatin or 10 μM β-amyloid peptide as indicated.
andD)Culturedhippocampal neuronswere incubatedwith 100ng/ml neocarzinostatin or
es (D), total RNA was extracted from neurons and subjected to Northern blot analysis.
ith similar results. Densitometric analysis of p19, p35 and CDK5 are represented in the
ed to compare samples obtained at different times with samples obtained at zero time
cells (right panel) were transfected with wild-type or mutant E2F decoy. After 24 h cells
jected to Northern blot analysis using a 32P-labeled probe speciﬁc for human p19 mRNA
dependent experiments with similar results. Densitometric analysis of p19 is represented
sed to compare each sample with mutant E2F decoy transfected and none treated samples
or equivalent amount of mutant plasmid (p19mutCAT), 4 μg pCEFL-β-galactosidase and
h 10 μM β-amyloid peptide. CAT activity was determined 24 h after β-amyloid treatment
respect to basal value of p19CAT which was set to 100. Bars represent the mean ± S.D. of
alyze data as indicated (*p b 0.05; ***p b 0.01). (G and H) Differentiated SH-SY5Y cells
ng/ml neocarzinostatin (H) for the indicated times. Equal amounts of whole cell extracts
re analyzedby SDS-PAGE and autoradiography (upper panels; P-p19, phosphorylatedp19)
ph of tree independent experiment with similar results. β-Amyloid peptide (β-am),
decoy), mutated decoy E2F oligonucleotide (E2Fmutdecoy), and optic densitometry (OD).
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was calculated as [correct alternations / maximum alternations] × 100.
Spatial learningwas evaluated using a two-trial recognitionmemory
test with the Y-maze [37]. The walls of the arms were transparent
allowing the mouse to see distal spatial landmarks. The inside of the
arms was identical providing no intramaze cues. Mice were placed
into one of the arms of the maze (start arm) and allowed to explore
the maze with one of the arms closed for 15 min (training trial). After
a 30 min intertrial interval, mice were returned to the Y-maze by plac-
ing them in the start arm and allowed to explore freely all three arms
of the maze for 5 min (test trial). The number of entries into and the
time spent in each arm, and the ﬁrst choice of entry were registered
from video recordings.
2.15. Fear conditioning test
The conditioning chamber was made of transparent acrylic
(24.5 × 24.5 × 42 cm) in a wooden box with a clear front lid. The
ﬂoor of the chamber consisted of parallel stainless steel grid bars, each
measuring 0.3 mm diameter and spaced 0.8 mm apart. The grid was
connected to a device to deliver the foot-shocks and tone presentations.
Before training, the animals were handled once a day for two days.
Training (day 1) consisted of placing the mouse in the chamber and
allowing a 2 min acclimatization period. After this period, the mouse
received three trials (with an intertrial interval of 1 min) of a tone pre-
sentation (10 s, 80 dB) which co-terminated with a foot-shock (0.6 mA,
1 s). After the ﬁnal trial, the mouse remained in the chamber for an ad-
ditionalminute andwas returned to its home cage. Contextual fear con-
ditioning during the test session was evaluated one day after training
(day 2) by placing each mouse in the training environment for 5 min
in the absence of the foot-shock and the tone. Animals were also tested
to the tone (cued fear conditioning) one day after the contextual test
(day 3). This test was performed by presenting the same tone used in
the training session, but in a modiﬁed context. Most of the contextual
cues present in the training contextwere changed (white ﬂoor, semicir-
cular green walls, vanilla odor, different chamber and room light inten-
sity, and absence of background noise). The tone was presented for
4 min after a baseline period of 2 min to evaluate pre-tone freezing.
Training, contextual and cued tests were videotaped to calculate
freezing.
Memory was assessed and expressed as the percentage of time that
the mice spent freezing, which is commonly used as an index of fear in
mice [38]. Freezing was deﬁned as the absence of movements except
those related to breathing, and was scored according to an instanta-
neous time-sampling procedure, in which each animal was observed
every 5 s (60 measures for the contextual memory test; and 72
measures for the cue memory test: 24 measures for the pretone and
48 measures for the tone).
2.16. Data analyses
Data were analyzed by unpaired two-tailed Student's t test. Quanti-
ﬁcation of γH2AX immunoﬂuorescence in hippocampus, spontaneous
alternation Y-maze test and contextual fear conditioning test were
statistically analyzed by one-way ANOVA, followed by Bonferroni's
post hoc test. When cued fear memory was assessed, behavioral data
were analyzed by two-way ANOVA, followed by Bonferroni's post hoc
test. Cued Y-maze test was analyzed using chi-square test.
3. Results
3.1. p19 is induced and phosphorylated in neuronal cells in response to
DNA damage
In a ﬁrst approach in order to contrast our hypothesis about the role
of p19 in the cellular response evoked by genotoxic-induced DNAdamage, we analyzed the expression of p19 in differentiated cells treat-
ed with β-amyloid peptide. To do this, human neuroblastoma SH-SY5Y
cells were incubated with 1 μM all-trans-retinoic acid (ATRA) for seven
days. The emergence of long and interconnected neurites, the
expression of microtubule-associated protein 2 from the third day of
incubation and the diminished expression of CDK2 indicate that cells
were differentiated to neuronal-type cells (Supplementary Fig. 1A–D).
Time-course experiments revealed that p19 mRNA expression was
early and signiﬁcantly induced upon treatment with 10 μM β-amyloid
in both differentiated and non-differentiated SH-SY5Y cells (Fig. 1A).
Similar results were observed in differentiated cells treated with
100 ng/ml neocarzinostatin (NCS) (Fig. 1B), a radiomimetic drug that
generates DNA-double strand beaks (Supplementary Fig. 1E and
Supplementary Fig. 4D). Induction of p19 expression was also detected
in the primary culture of rat hippocampal neurons incubated with NCS
or β-amyloid peptide (Fig. 1C) or 1 μM camptothecin (Fig. 1D). This
induction appears to be attributable to transcriptional regulation and
mediated by E2F transcription factor since SH-SY5Y cells transfected
with the decoy oligodeoxynucleotide containing a wild type version of
the E2F consensus binding sequence and treated with β-amyloid,
showed lower p19 induction than cells transfected with the decoy
containing a mutated version of the E2F binding site (Fig. 1E). Similarly,
the β-amyloid-mediated induction of a reporter construct harboring a
2307-bp fragment derived from the human p19 promoter was partially
repressed in cells co-transfected with the wild type decoy but not in
those co-transfected with the mutated version or when the two E2F
binding sites in the p19 promoter were mutated (Fig. 1F).
p19 not only showed increased expression, butwas also phosphory-
lated by incubation of differentiated SH-SY5Y cells with β-amyloid
peptide or NCS (Fig. 1G and H), as we had observed in non-neuronal
cells under stress conditions [34]. p19 phosphorylation was detectable
within 30–60 min and maintained for at least 24 h after β-amyloid
treatment or 8 h after incubation with NCS.
Interestingly, p19 mRNA and protein levels were increased during
the differentiation process with ATRA (Supplementary Fig. 2A and B).
p19 protein was four or ﬁve times higher in neuronal-type cells than
in non-differentiated cells and remained increased along the experi-
mental period. This induction in p19 expression could be due to the
action of the transcription factor Egr-1, which was induced during
differentiation itself (Supplementary Fig. 2A). Besides the presence of
several putative Egr-1 binding sites on the p19 promoter, two experi-
mental evidences strongly support this hypothesis. First, overexpression
of Egr-1 induced p19 expression in SH-SY5Y cells in the absence of any
differentiation stimulus. Second, in ATRA-stimulated SH-SY5Y cells
previously incubated with an Egr-1 antisense oligodeoxynucleotide,
p19 induction was almost completely blocked although the differentia-
tion process progressed without changes (Supplementary Fig. 2C–E).
The following experiments, unless otherwise mentioned, were
carried out in SH-SY5Y differentiated cells.
3.2. p19 phosphorylation depends on CDK5 activity
Recently, we have demonstrated that CDK2 phosphorylates p19 in
serine 76 upon UV-induced DNA damage [34]. This serine is located in
a consensus motif for CDK1/CDK2/CDK5 phosphorylation. In view of
the high activity of CDK5 in neuronal cells, we next attempted to ﬁnd
out whether p19 is a physiologically relevant target of this kinase
under DNA damage conditions. In agreement with previous reports
[39,40], we found that β-amyloid induced a sustained activation of
CDK5 (Fig. 2A). Surprisingly, NCS promoted an increase in CDK5 activity
as well (Fig. 2A). As expected, enhancement of CDK5 kinase activity by
NCS promoted phosphorylation of ATM, a CDK5 substrate [41] (Fig. 2B).
As the kinase activity of CDK5 is dependent on its activator p35,we next
examined the levels of p35 and CDK5 transcripts. The levels of p35
mRNA, but not of CDK5, increased within 2 h after β-amyloid or NCS
incubation in both SH-SY5Y differentiated cells (Fig. 1A and B) and
Fig. 2. p19 phosphorylation depends on CDK5 activity in damaged neuronal type cells. (A) In vitro kinase assays were performed using immunoprecipitated CDK5 from differentiated
SH-SY5Y cells previously treated or not with 10 μM β-amyloid peptide or 100 ng/ml neocarzinostatin. Histone H1 derived peptide was used as a speciﬁc substrate to measure kinase
activity. Measurements were done in triplicates and bars show themean± S.D. of three independent experiments. Student's t-test was used to compare treated and non-treated samples
(**p b 0.02). (B) Differentiated SH-SY5Y cells were treatedwith 100 ng/ml neocarzinostatin during 0.5, 2 and 4 h.Whole-cell extracts were prepared and analyzed byWestern blotting for
phosphoATM (s1981), ATM and β-actin. The ﬁgure is a representative of three independent experiments with similar results. (C) Differentiated SH-SY5Y cells were treated with 10 μM
β-amyloid or 100 ng/ml neocarzinostatin and harvested at different time points. Cultured hippocampal neurons were incubated with 10 μM β-amyloid peptide or 100 ng/ml NCS and
harvested 4 h after treatments. The expression of CDK5, p35 and p25 were evaluated by Western blot using speciﬁc antibodies. The ﬁgure is a representative of three independent
experiments with similar results. (D) Differentiated SH-SY5Y cells were transfected with an antisense oligodeoxynucleotide to CDK5 (CDK5AS) or its scrambled version (Scr). After
24 h, cells were labeled with [32P]-orthophosphate for 3 h and then treated with 10 μM β-amyloid peptide. (E) Differentiated SH-SY5Y cells were labeled with [32P]-orthophosphate
for 3 h, pre-treatedwith 10 μMbutyrolactone-I for another 2 h and then damagedwith 10 μM β-amyloid peptide. (D and E) At the indicated time points, endogenous p19 phosphorylation
was analyzed by SDS-PAGE and autoradiography (upper panels; P-p19, phosphorylated p19) or immunoblotting (lower panels; p19). Theﬁgure shows a representative autoradiograph of
three independent experimentswith similar results. (F) Differentiated SH-SY5Y cells were transfectedwith an antisense oligodeoxynucleotide to CDK5 (CDK5AS) or to CDK2 (CDK2AS) or
their respective scrambled sequence (Scr). After 24 h, cells were labeled with [32P]-orthophosphate for 3 h and then treated with 10 μM β-amyloid peptide for 2 h. Endogenous p19
phosphorylation was analyzed by SDS-PAGE and autoradiography. The ﬁgure shows a representative autoradiograph of three independent experiments with similar results. (G) In
vitro kinase assays were performed using immunoprecipitated CDK5 from β-amyloid-damaged SH-SY5Y cells and recombinant GST-p19. Histone H1 was used as a control for CDK5
activity. The control lane 1 belongs to the same gel (left panel). Aliquots of each sample were electrophoresed and the presence of GST-p19 was analyzed by Western blot using an
anti-p19monoclonal antibody (right panel). The ﬁgure shows a representative autoradiograph of three independent experiments with similar results. (H) A synthetic peptide containing
the sequence in which S76 (p-S76) is positioned, was used to perform in vitro kinase assays. p-S76 peptide was incubated with CDK5 immunoprecipitated from β-amyloid-damaged
SH-SY5Y cells. A histone H1 peptide (p-H1) was used as a speciﬁc substrate for CDK5 as a control of enzymatic activity. Measurements were done in triplicates and bars show the
mean ± S.D. of three independent experiments. Student's t-test was used to compare substrates containing samples with samples without substrate (none) (*p b 0.05). (I and J)
HEK293 cells were cotransfected with CDK5, p35, p25 or CDK5D144N expression vectors along with pBabe-Puro. Twenty-four h after transfection cells were treated with 1 μg/ml
puromycin and incubated for another 48 h. In (I), differentiated SH-SY5Y cells and resistant HEK293 cells were damaged with 10 μM β-amyloid peptide for 2 h and cell extracts were
used to perform in vitro CDK5kinase assay.Measurementswere done in triplicates and bars show themean±S.D. of three independent experiments. Student's t-testwas used to compare
treated vs. non-treated SH-SY5Y cells and CDK5 + p35 vs. CDK5+ p25 transfected HEK293 cells (*p b 0.05). In (J) puromycin resistant cells were labeled with [32P]-orthophosphate for
3 h, treated with 10 μM β-amyloid peptide and collected 2 h after damage. Extracts were subjected to immunoprecipitation with antip19 antibody and phosphorylated p19 (P-p19) was
analyzed by autoradiography. The levels of endogenous p19 and transfected CDK5 and p35/p25were also controlled byWestern blot. Theﬁgure shows a representative autoradiograph of
three independent experiments with similar results. β-Amyloid peptide (β-am), neocarzinostatin (NCS), and butyrolactone-I (BL-I).
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p25 by β-amyloid or NCS was observed in both SH-SY5Y differentiated
cells and hippocampal neurons (Fig. 2C). These results indicate that
expression and proteolysis of p35 are strongly induced by these
genotoxics and that kinase activity of CDK5 is thereby greatly enhanced.
To determine whether increased CDK5 activity is required for
β-amyloid-mediated induction of p19 phosphorylation, cells were
either previously transfected with a CDK5 antisense oligode-
oxynucleotide or treated with butyrolactone-I, a CDK5 inhibitor, to
decrease this kinase activity (Supplementary Fig. 3A and B). We found
that the antisense oligodeoxynucleotide totally inhibited while
butyrolactone promoted a signiﬁcant decrease in p19 phosphorylation
(Fig. 2D and E). Unlike non-neuronal cells, in which the genotoxic trig-
gers CDK2-dependent p19 phosphorylation [34], postmitotic neurons
appear to activate CDK5 to target p19 under a stress stimulus, as
suggested by the results shown in Fig. 2F. The CDK5, but not the CDK2
antisense oligonucleotide to CDK5, was able to suppress the p19 phos-
phorylation induced by incubation with β-amyloid peptide (Fig. 2Fand Supplementary Fig. 3C–E). On the other hand, induction of p19
expression seemed to be independent of CDK5 (Supplementary Fig. 3F
and G).
To investigate whether p19 is a direct target of CDK5 we carried out
in vitro kinase assays using recombinant GST-p19 protein or speciﬁc
p19 derived peptide containing serine 76 as substrates with CDK5
immunoprecipitated from SH-SY5Y cells. The results showed that
CDK5 was able to efﬁciently phosphorylate both the puriﬁed GST-p19
and the S76-containing peptide (Fig. 2G and H). These results indicate
that p19 is a proper substrate for the CDK5 activity. It is important to
note thatwe have previously demonstrated thatmutation in S76 render
a non-phosphorylatable p19 protein [34].
To further examine the requirement for CDK5 activity, we carried
out p19 phosphorylation assays in non-neuronal cells lacking endoge-
nous p35 expression. HEK293 cells were transfectedwith an expression
vector encoding CDK5, and/or p35 and/or p25 to reconstitute CDK5
activity in these cells (Fig. 2I). Incubation with a β-amyloid peptide
phosphorylated p19 in HEK293 cells probably through activation of
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CDK5/p35 or CDK5/p25 led to a robust p19 phosphorylation in the
absence of genotoxic stimuli (Fig. 2J). Overexpression of a dominant
negative form of CDK5 with p25 alone severely impaired CDK5 activity
and p19 phosphorylation was no longer observed.
Together these results indicate that increased CDK5 activity, in
response to β-amyloid or NCS, is required for p19 phosphorylation in
neuronal-type cells.
3.3. An increase in intracellular calcium recapitulates the DNA damage-
mediated effect on p19 expression
It is known that β-amyloid-mediated activation of CDK5 caused by
the stimulation of the proteolytic activity of calpain over p35 rendered
the more potent CDK5 regulatory subunit, p25. Calpain activity is
increased in response to the increased inﬂux of calcium ions in neuronal
cells promoted by incubation with β-amyloid. In view of this, we asked
whether increasing intracellular levels of calcium, in the absence of
genotoxics, would be sufﬁcient to modify p19 expression and phos-
phorylation. To test this, differentiated SH-SY5Y cells were incubated
with the calcium ionophore A23187. We found that p19 expression
and phosphorylation were increased in response to the calcium iono-
phore to levels comparable to those observed in the presence of
β-amyloid peptide (Fig. 3A–C).
To further assess the role of calcium, differentiated cells were
incubated with a medium containing ten times higher potassium con-
centration to trigger membrane depolarization and increase the levels
of intracellular calcium. Like that observed after incubation with the
ionophore, p19 expression and phosphorylation were increased after
membrane depolarization. Again, p19 phosphorylation was dependent
on CDK5 activity as it was inhibited by incubation with butyrolactone
(Fig. 3D–F). Interestingly, in this case, p19 inductionwas also dependent
on CDK5 activity. These observations were not a mere effect of an
increased saline concentration or osmolarity of the cell incubation
medium because a similar concentration of NaCl or mannose addition
caused no changes in p19 mRNA expression or p19 phosphorylation
(Fig. 3D–F). To conﬁrm that these effects were dependent on the
increased levels of intracellular calcium, we incubated cells in each of
the above conditions in the presence of EGTA to quelate calcium
ions. Both the induction and phosphorylation of p19 mediated by
β-amyloid, NCS or high potassium concentration were severely
impaired in the presence of EGTA (Fig. 3G and H).Fig. 3. Increased levels of intracellular calcium cause the induction and phosphorylation of p19
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treated samples (**p b 0.02; ***p b 0.01, at least). β-Amyloid peptide (β-am), mannose (Ma), bAs already mentioned, DNA damage in neuronal cells promotes
and increases CDK5 activity mainly caused by the calpain-mediated
cleavage of p35 to p25. Then, we tested whether p19 phosphorylation
in response to DNA damage or increased calcium levels is dependent
on calpain proteolytic activity. Differentiated SH-SY5Y cells were
cotreatedwith β-amyloid, NCS or A23187 ionophore and the calpain in-
hibitor calpeptin. We found that calpeptin partially inhibited the p19
phosphorylation (Fig. 3I). As expected, the induction of CDK5 activity
promoted by incubation with the genotoxics or the ionophore was
blocked by calpeptin (Fig. 3J).
3.4. CDK5-mediated phosphorylation stabilizes p19 protein
In a previous work we have demonstrated that UV irradiation of a
great number of different cells leads to p19 induction of both mRNA
and protein expression ([25] and Supplementary Fig. 4A). However,
in spite of the increase in p19 mRNA expression in response to
β-amyloid or NCS treatment, we found no signiﬁcant increase in p19
protein levels in neuronal cells (Fig. 4A). Similar results were obtained
in Neu-2a cells and primary cultures of rat hippocampal neurons
(Supplementary Fig. 4B–D).
Consistent with a previous report [42], we found that p19 protein is
degraded by calpain protease (data not shown). Therefore, the same
mechanism leading to CDK5 activation in response to intracellular
calcium inﬂux and mediating induction of p19 expression and phos-
phorylation, could be involved in p19 partial degradation. To test the
above hypothesis, we determined the effect of β-amyloid peptide on
p19 protein expression in the presence of the calpain inhibitor,
calpeptin. We found increased levels of p19 protein when cells were
coincubated with β-amyloid and calpeptin (Fig. 4B). Similar results
were obtained in differentiated SH-SY5Y cells incubated with NCS
along with calpeptin (Fig. 4C). Thus, these results indicate that p19 is
subjected to calpain degradation activated by increased intracellular
calcium levels.
Next, we askedwhether p19 phosphorylation could be related to its
degradation upon calpain activation.When differentiated SH-SY5Y cells
were preincubatedwith a CDK5 antisense oligodeoxynucleotide orwith
the CDK5 inhibitor butyrolactone and then treatedwithβ-amyloid pep-
tide, p19 protein levels were lower than those in cells preincubated
with the scrambled oligodeoxynucleotide or vehicle alone (Fig. 4D
and E). To further conﬁrm the function of phosphorylation on p19
stability, we conducted experiments in differentiated SH-SY5Y cells. (A) Differentiated SH-SY5Y cells were incubated with 5 μM A23187 or 10 μM β-amyloid
ted from cells and subjected to Northern blot analysis using the [32P]-labeled probes spec-
ilar results. Densitometric analysis of p19, p35 and CDK5 are represented in the right panel.
ples obtained at different timeswith samples obtained at zero time (*p b 0.05; **p b 0.02).
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lexes were analyzed by SDS-PAGE and autoradiography (upper panels; P-p19, phosphor-
iograph of three independent experiments with similar results. (C) In vitro kinase assays
treated with 10 μM β-amyloid peptide or 5 μM A23187. Histone H1 derived peptide was
d bars show themean± S.D. of three independent experiments. Student's t-test was used
ously treatedwith 10 μMbutyrolactone-I for 2 h,were incubatedwith 1%mannose, 45mM
to Northern blot analysis using a [32P]-labeled probe speciﬁc for human p19 mRNA and
ith similar results. Densitometric analysis of p19 is represented in the right panel. Bars rep-
d non-treated samples (*p b 0.05; **p b 0.02). (E) Differentiated SH-SY5Y cells previously
extracts were used to analyze endogenous p19 phosphorylation by immunoprecipitation
periment with similar results. (F) Immunoprecipitated CDK5 from differentiated SH-SY5Y
re done in triplicates and bars show the mean ± S.D. of three independent experiments.
***p b 0.01, at least). (G) Differentiated SH-SY5Y cells were pre-incubated with 250 μM
or 45 mM KCl. After 4 h, the expression of p19 was analyzed by Northern blot. The ﬁgure
alysis of p19 is represented in the right panel. Bars represent the mean ± S.D. of three
; **p b 0.02; ***p b 0.01). (H) Differentiated SH-SY5Y cells previously labeled with [32P]-
whole protein extracts were used to analyze endogenous p19 phosphorylation by immu-
independent experimentswith similar results. (I) Differentiated SH-SY5Y cells previously
with 10 μMβ-amyloid peptide, 100 ng/ml neocarzinostatin or 5 μMA23187 for additional
ylation by immunoprecipitation and autoradiography. The ﬁgure shows a representative
assay was performed using immunoprecipitated CDK5 from differentiated SH-SY5Y cells
. of three independent experiments. Student's t-test was used to compare treated and non-
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wild type or mutant versions in which S76, the site of CDK5-mediated
phosphorylation,was replaced by alanine or glutamic acid. In a previous
work, we demonstrated that S76Emimics p19 phosphorylation [34]. As
expected, p19wt-V5 levels were decreased in cells overexpressing
calpain. Moreover, p19S76A-V5 levels were much lower in thisFig. 4. CDK5-mediated phosphorylation stabilizes p19 protein. (A) Differentiated SH-SY5Y cel
lysates prepared at the indicated times. Western blot analysis of p19 and CDK5 were carried
CDK5 polyclonal antibody respectively. The ﬁgure is a representative of three independent ex
the lower panels. Bars represent the mean ± S.D. of three experiments. (B and C) Differentiat
10 μM β-amyloid peptide (B) or 100 ng/ml neocarzinostatin (C). Cell lysates were prepared at
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with wild type p19 (p19wt) or p19 mutants (p19S76A, p19S76ET141E) along with an expres
Twenty-four hours after transfection, cells were treated with 1 μg/ml puromycin and incubate
and collected 12 h after treatment. Western blot analysis of p19-V5 was carried out with 20 μg
representative of three independent experiments with similar results. Densitometric analy
experiments. Student's t-test was used to compare Cpn28K transfected and non-transfecte
butyrolactone-I (BL-I), calpeptin (calp), Cpn28K (C28K), and optic densitometry (OD).condition. Conversely, expression levels of the p19S76ET141E-V5
mutant were not modiﬁed in cells transfected with a vector encoding
calpain (Fig. 4F). As expected transfected calpain induced p35 cleavage
partially inhibited by calpeptin treatment (Supplementary Fig. 4E). We
measured CDK5 activity to conﬁrm the activity of overexpressed calpain
(Supplementary Fig. 4F). The results strongly suggest that S76-p19ls were incubated with 10 μM β-amyloid peptide or 100 ng/ml neocarzinostatin and cell
out with 20 μg of total cellular proteins and detected with p19 monoclonal antibody or
periments with similar results. Densitometric analysis of p19 and CDK5 is represented in
ed SH-SY5Y cells were pre-treated with 10 μM calpeptin for 2 h and then incubated with
the indicated times following DNA damage treatment and the expression of p19 protein
dent experiments with similar results. Densitometric analyses of p19 are represented in
st was used to compare treated and non-treated samples (*p b 0.05). (D) Differentiated
its scrambled sequence (Scr). After 24 h, cells were treated with 10 μM β-amyloid peptide
roteins and detected with p19 monoclonal antibody. The ﬁgure is a representative of four
the lower panel. Bars represent the mean ± S.D. of four experiments. Student's t-test was
ated SHSY5Y cells were pre-treatedwith 10 μMbutyrolactone-I for 2 h and then incubated
the expression of p19 protein was analyzed byWestern blot. Results are representative of
d in the lower panel. Bars represent themean± S.D. of three experiments. Student's t-test
ells were transiently co-transfected with expression vectors encoding the V5-tag in frame
sion vector encoding the 28 kDa small subunit of rat calpain (Cpn28K) and pBabe-Puro.
d for another 24 h. Resistant SH-SY5Y cell were damaged with 10 μM β-amyloid peptide
of total cellular proteins and detected with anti-V5 monoclonal antibody. The ﬁgure is a
ses of p19 are represented in the right panels. Bars represent the mean ± S.D. of three
d samples (*p b 0.05; **p b 0.02). β-Amyloid peptide (β-am), neocarzinostatin (NCS),
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tein against calpain-mediated degradation.3.5. p19 improves DNA repair, diminishes apoptosis and increases neuronal
survival under genotoxic stress
As previously mentioned, p19 is a cell cycle inhibitor which has also
a role in the DNA damage response. To determine whether p19 partici-
pates in the maintenance of DNA integrity in neuronal cells we ﬁrst
carried out an unscheduled DNA synthesis (UDS) assay in differentiated
SH-SY5Y neuronal cells stably transfected with cDNA expressing p19
sense or p19 antisense driven by metallothionein promoter stimulated
by Zn2+ addition to the culture medium. p19 expression was assessed
by Northern blot and clones providing maximal and minimal p19
expression were selected (Supplementary Fig. 5A and B). In addition,
expression of endogenous p19 was not affected by 100 μM Zn2+
(Supplementary Fig. 5C). We observed that β-amyloid-treated cells
overexpressing the p19 sense displayed greater DNA repair synthesis
than cells transfected with the empty vector (Fig. 5A). In contrast,
DNA repair synthesis was markedly decreased in β-amyloid or NCS-
treated cells overexpressing p19 antisense (Fig. 5A and Supplementary
Fig. 5D). This decrease in UDS indicates not only that DNA repair
enhancement results speciﬁcally from p19 overexpression but also
that endogenous p19 is necessary to achieve a complete response to
DNA damage. In addition, hippocampal neurons with deﬁcient levels
of p19 (Supplementary Fig. 5E) displayed a decreasedDNA repair capac-
ity after damage by β-amyloid peptide (Fig. 5B) or NCS (Supplementary
Fig. 5F).
In view of the ability of p19 to maintain DNA integrity, we next
attempted to ﬁnd out whether apoptosis caused by DNA-damaging
agents correlates with p19 levels. To do this, we determined the activity
of caspase-3, an effector caspase that accomplishes the ﬁnal cell death
program, in differentiated SH-SY5Y cells expressing p19 sense or
antisense deoxyoligonucleotide and rat hippocampal neurons with
deﬁcient levels of p19. The induction of caspase-3 activity revealed that
neuronal cells underwent apoptosis after genotoxic damage (Fig. 5C
and D). We also showed that Zn2+ addition to culture medium did
not modify its activity (Supplementary Fig. 5G). The extent of induction
of caspase-3 activity was decreased in cells transfected with the p19
sense deoxyoligonucleotide. Conversely, a signiﬁcant increase in
caspase-3 activity was observed in NCS-treated hippocampal neurons
or SH-SY5Y cells with deﬁcient levels of p19 (Fig. 5C and D). In addition,
a similar increase was observed in β-amyloid-treated hippocampal
neurons with deﬁcient levels of p19 (Fig. 5D). Importantly, p19-
deﬁcient hippocampal neurons showed a signiﬁcant greater level of
caspase-3 activity even in the absence of genotoxics, suggesting that
p19 displays a more general protective role in preserving genomic
integrity (Fig. 5D).
To address whether the downregulation of p19 has any biological
signiﬁcance and plays any functional role in the cellular response
upon genotoxic treatment, we examined cell survival in differentiated
SH-SY5Y cells and neurons from rat hippocampus. Both p19-deﬁcient
neurons and SH-SY5Y cells overexpressing antisense p19 deoxyoligo-
nucleotide were more sensitive to β-amyloid or NCS damage
(Fig. 5E–G). On the other hand, we observed no signiﬁcant differences
in the cell survival of NCS-treated SH-SY5Y cells overexpressing sense
p19 deoxyoligonucleotide (Supplementary Fig. 5H). Control assays
showed that the presence of ZnSO4 had no effect on cell proliferation
(Supplementary Fig. 5I).
To further analyze the long-term effects and physiological relevance
of p19 in cell survival in neurons, we performed clonogenic assays. The
dose–response curve differed signiﬁcantly depending on p19 status.We
found that 99% and 73% of the colonies from p19 normal cells survived
at 1 and 2 ng/ml NCS, respectively, while 62% and 41% remained alive at
the same doses (Fig. 5H). Collectively, these results indicate that p19inﬂuences neuronal sensitivity to DNA damagers thus providing a
remarkable advantage against genotoxic stress.
3.6. In vivo p19 deﬁciency makes hippocampal cells more sensitive to
genotoxic stress
Next, we examined whether the neuroprotective properties of p19
could be recapitulated in an in vivo mouse model. To do this, a single-
stranded DNA oligonucleotide containing an antisense sequence of
p19 was laterally injected by stereotaxis in the dorsal hippocampus to
selectively knock down the p19 expression (Fig. 6A). The injected
oligodeoxynucleotidewas able to decrease p19 expression in the hippo-
campus and Neu-2a cells (Supplementary Fig. 6A and B). A scrambled
oligodeoxynucleotide, injected in the contralateral hippocampus was
used as a control for the non-speciﬁc actions of DNA administration.
After 16 h, 0.5 ml of 25 ng/ml NCS or saline solution was administered
in each hippocampus. The time and concentration to which genotoxic
was injected arose from a time- and dose–response curves performed
previously (Supplementary Fig. 6C). The NCS concentration selected
represents the minimum dose of genotoxic that causes a signiﬁcant
DNA damage measured as the number of γH2AX-positive cells. Brain
sections were examined 24 h later for γH2AX immunoreactivity to
label DNA damaged cells. Administration of NCS in the dorsal region of
the hippocampus caused an increase in γH2AX-positive cells. Impor-
tantly, the number of DNA damaged cells was almost two-fold higher
in the hippocampus from mice previously injected with p19 antisense
oligodeoxynucleotide (Fig. 6B and C). Interestingly, in the absence of
genotoxic administration, a slight but signiﬁcant increase in γH2AX-
positive cells was observed in the hippocampus from mice injected
with the p19 antisense deoxyoligonucleotide compared with those
injected with the scrambled one. These results strongly support a
role of p19 in the maintenance of genomic integrity in the mouse
hippocampus.
3.7. Mice with a p19 hippocampal deﬁciency display impairment of
cognitive skills after genotoxic stress
In viewof the fact that thepresence of p19 contributes to attenuating
the effect of genotoxics to DNA integrity in the hippocampus of the
mouse brain, we hypothesize that p19 could ameliorate the adverse
consequences on hippocampus-dependent tasks in a brain exposed to
DNA stressors. To test this hypothesis, mouse brains were bilaterally
injected in the dorsal hippocampus with p19 antisense (ASp19) or
scrambled (Scr) oligodeoxynucleotides. Sixteen hours later, mice were
injected with either NCS or saline solution. Hippocampal-dependent
learning andmemory ofmicewere studied usingY-maze tests.Working
memory was ﬁrst assessed using the spontaneous alternation proce-
dure, a non-aversive task based on exploratory behavior and allowing
differentiation between mnesic and locomotor behaviors. One-way
ANOVA indicated that spontaneous alternation behavior in the Y-maze
was affected by the treatment (F2,29 = 11.52, p= 0.0002). Bonferroni
post hoc comparisons showed a signiﬁcant decrease in the spontaneous
alternation in ASp19 + NCS treated-mice compared with Scr + saline
(t18 = 4.697, p b 0.001) or with Scr + NCS (t18 = 3.207, p b 0.05)
(Fig. 7A). This observation could not be attributed to an effect on the
motor activity because the total distance traveled (Fig. 7B) and the
number of arm entries (Fig. 7C) in the Y-maze task was not signiﬁcantly
different between the groups. This observation can neither be attributed
to an aversive behavior because the distance traveled (Supplementary
Fig. 7A–C) and the time spent (Supplementary Fig. 7D–F) in each arm
was not different between the three groups. These results suggest a
deleterious effect of the deﬁcient expression level of p19 on short-
term spatial memory.
Next, mice from all three groups were evaluated in spatial learning
using a two-trial recognition memory test with the Y-maze device.
Mice from the Scr + saline and Scr + NCS groups entered more
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of the maze. No signiﬁcant differences were observed between both
groups (arm entry: t18 = 0.7610, p = 0.2283; dwell time: t18 =
0.3613, p = 0.3610) (Supplementary Fig. 8A and B). In contrast, the
ASp19 + NCS group mice showed no preference toward the novel
arm and entered the different arms randomly (arm entry: t18 = 1.812,
p= 0.0434; dwell time: t18 = 2.665, p= 0.0079). The deﬁcit in spatial
memory of ASp19 + NCS mice was evident also when the arm chosen
for the ﬁrst entry was compared with that chosen by Scr + saline
mice group (χ2 = 3.810, df = 1, p = 0.0255) (Fig. 7D). Conversely,
most Scr + saline and Scr + NCS mice groups selected the novel arm
as theﬁrst choice, and no signiﬁcant differenceswere observedbetween
both groups (χ2 = 0.3922, df= 1, p= 0.2656).We next performed a fear conditioning test to further evaluate the
consequences of p19 deﬁciency in the hippocampus in a DNA damage
context. Mice were trained using the Pavlovian fear conditioning
paradigm 24 h before a memory test. One-way ANOVA indicated that
the freezing behavior of mice was affected by the treatment (F2,25 =
6.255, p = 0.0063) (Fig. 7E). Bonferroni post hoc analysis revealed
that ASp19 + NCS mice exhibited signiﬁcantly reduced freezing
behavior than Scr + saline (t16 = 2.780, p b 0.05) and than Scr +
NCS mice (t17 = 3.304, p b 0.01). Consistent with the notion that the
hippocampus is not required for cued fear conditioning [43], the two-
way ANOVA showed no signiﬁcant differences for treatment (F2,27 =
0.4668, p = 0.8831) in the tone-dependent memory test (Fig. 7F).
Next, mice were subjected to a novel object recognition task that relies
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spent exploring the novel object were observed between the three
groups (F2,26 = 0.4180, p= 0.6627) (Supplementary Fig. 8C).
Finally, mouse performance in non-hippocampus-dependent tasks
was similar in all the three groups tested. Neither the neuromuscular
coordination, evaluated by means of tightrope test, nor the muscle
strength, assessed in a hangwire test, showed signiﬁcant differences
between groups (Supplementary Fig. 8D and E). Likewise, no forelimb
asymmetries, assessed in the rearing test, were detected in mice of
any of the three groups (Supplementary Fig. 8 F).
4. Discussion
Neurons formed during early development are preserved for life
and therefore face the task of maintaining a stable genome for long
periods of time. DNA damage, which perturbs genomic stability, has
been related to cognitive decline in the aging human brain [44]. In addi-
tion, mutations in DNA-repair genes have neurological implications
[45]. Several studies have suggested that DNA damage is also increased
in disorders such as Alzheimer's disease, Parkinson's disease and amyo-
trophic lateral sclerosis [7,46]. However, the precise mechanisms
connecting DNA damage with neurodegeneration remain poorly
understood.
Overall, our data show that p19 contributes to the maintenance of
genomic integrity in nervous system cells challenged by neurotoxic
conditions preserving their functionality. We found that exposure of
differentiated human neuroblastoma cells or rat hippocampal neurons
to β-amyloid peptide or NCS induce changes in p19 cellular status
including transcriptional activation and protein phosphorylation. p19
induction and phosphorylation are also accomplished by the increase
in intracellular calcium. Increased intracellular calcium levels trigger
the depolarization of mitochondrial membrane and subsequent loss of
membrane potential, which is accompanied by the generation of ROS
which, in turn, cause DNA damage [47].
It has beenpreviously demonstrated that p19 protein contains a CDK
phosphorylation site located in Ser 76 that is crucial for p19 function in
DNA repair and cell survival [34]. The data presented in this study
indicate that CDK5 is speciﬁcally involved in p19 phosphorylation in
response to DNA damage. Several results support this statement.
First, differentiated SH-SY5Y cells incubated with CDK5 antisense
deoxyoligonucleotide, but not with CDK2 antisense, resulted in theFig. 5. p19 enhances the ability to repair DNA lesions and confers resistance to β-amyloid and n
SY5Yp19AS cells weremaintained in amedium containing 0.5% fetal bovine serumduring 24 h,
10 μM β-amyloid peptide, incubated with 10 μCi [3H]thymidine and cell lysates were tested
experiments performed in triplicate. Student's t-test was used to compare β-amyloid-treated
stable transfectant samples at 10 h (*p b 0.05; ***p b 0.01). (B) Hippocampal neurons were t
and, 24 h later, incubated with 10 μM β-amyloid peptide and 10 μCi/ml [3H]-thymidine. Follow
different experiments performed in triplicate. Student's t-test was used to compare β-amyloid
12 h (*p b 0.05). (C) Differentiated SH-SY5Yp19S, SH-SY5Yp19AS or SH-SY5Yempty cells we
were treated with 10 μM β-amyloid peptide or 100 ng/ml neocarzinostatin. Twenty-four hour
of caspase-3 activity with respect to basal activity of cell lysates stably transfected with em
mean ± S.D. of three independent experiments performed in quadruplicate. Student's t-tes
transfectants samples with β-amyloid-treated or NCS-treated empty vector stable transfec
transfected with p19 antisense oligonucleotide (p19AS) or its scrambled sequence (Scr) and, 2
ately and 24 h after damage, cell lysateswere tested for caspase-3 activity. Results are expressed
with scrambled oligonucleotide and without damage treatment measured at time point 0 h, w
performed in quadruplicate. Student's t-test was used to compare p19AS transfectant samples
SH-SY5Yp19AS were maintained in basal medium or medium containing 100 μM ZnSO4 durin
times, cell viabilitywas assessed byMMT reduction assay. Results are expressed at percentage o
time point 0 day, which was set to 100. Bars represent the mean ± S.D. of three independent ex
samples and ZnSO4 non-treated samples (***p b 0.01; ****p b 0.005). (F and G) Hippocampal
sequence (Scr) and, 24 h later, incubated with 10 μM β-amyloid peptide (F) or 50 ng/ml neo
assay. Results are expressed at percentage of cell viability with respect to viability of cells tran
to 100. Bars represent the mean ± S.D. of three independent experiments performed in sextu
transfected samples (**p b 0.02; ***p b 0.01; ****p b 0.005). (H) Clonogenic survival was asse
Left panel shows representative colony images of each treatment. Right panel shows the qua
respect to colonies of untreated cells, which was set to 100. Bars represent the mean ± S.D. o
compare ZnSO4 treated samples and ZnSO4 non-treated samples (*p b 0.05). Neocarzinostatininhibition of DNA damage-mediated p19 phosphorylation. Second,
cells treated with butyrolactone-I, a CDK5 inhibitor, abolished p19
phosphorylation. Finally, reconstituted CDK5 activity in non-neuronal
cells not expressing endogenous CDK5 activity recapitulates p19 phos-
phorylation in the absence of DNA damage stimuli. Together, these
ﬁndings indicate that CDK5 activation and p19 phosphorylation in
postmitotic neuronsmay represent amode of response to awider spec-
trum of signals.
The protease calpain is known to be stimulated under genotoxic
stress, increased intracellular calcium or neurological damage condi-
tions [48,49]. In these conditions, CDK5 hyperactivation results from
the accumulation of p25 from the cleavage of p35 by pathogenic activa-
tion of calpain. p25 ismore stable than p35 and therebymaintains CDK5
in a hyperactive state. The binding of p25 to CDK5 is also thought to
change CDK5 subcellular localization from the plasma membrane to the
cytoplasm and nucleus, potentially altering CDK5 substrate speciﬁcity
[50]. Although the identity and localization of these pathogenic sub-
strateswere ﬁrst unclear, recent reports have shown that aberrant cyto-
plasm CDK5 activity phosphorylates peroxiredoxin-2, decreasing its
peroxidase activity and decreasing the capacity of cells to reduce ROS
[51]. Furthermore, the apurinic/apyrimidinic endonuclease 1, which
plays an essential role in the base excision repair pathway, has been
recently identiﬁed as a target of the nuclear CDK5 activity, interfering
with the repair of this type of DNA damage [52]. This dysregulation of
CDK5, found in neuronal DNA damage response, is neurotoxic and
may contribute to the pathogenesis of neurodegenerative disorders.
In this regard, the inhibition of calpain with the inhibitor calpeptin
clearly decreased not only CDK5 activity, but also p19 phosphorylation.
This close correlation suggests an upstream pathway for p19 phosphor-
ylation formed by calpain activation, p35 to p25 cleavage and
subsequent increased CDK5 activity. Since p19 is also targeted by
calpain-protease activity CDK5-mediated p19 phosphorylation was
crucial to increase its stability. The fact that p19S76A mutant levels
were rapidly decreased in response to genotoxics while its counterpart
in which Ser76 was changed by a negative charged aminoacid mimic
the phosphate residue did not, correlate in support.
Besides its phosphorylation, we demonstrated that in response to
DNA damage p19 expression is transcriptionally induced and mediated
by E2F transcription factors. These ﬁndings prompted us to hypothesize
that the p19 protein level observed in neuronal cells treated with
β-amyloid peptide or NCS is the result of a dynamic equilibriumeocarzinostatin in neuronal cells. (A) Differentiated SH-SY5Yempty, SH-SH5Yp19S or SH-
and incubatedwith 100 μMZnSO4 for another 16 h. After this time, cells were treatedwith
for UDS assay at different time points. Bars represent the mean ± S.D. of three different
p19 sense or antisense stable transfectant samples with β-amyloid-treated empty vector
ransfected with p19 antisense oligonucleotide (p19AS) or its scrambled sequence (Scr)
ing 12 h, cell lysates were tested for UDS assay. Bars represent the mean ± S.D. of three
-treated p19AS transfectant samples with β-amyloid-treated Scr transfectant samples at
re maintained in a medium containing 100 μM ZnSO4 during 16 h. After this time, cells
s later, cell lysates were tested for caspase-3 activity. Results are expressed as percentage
pty vector and without damage treatment, which was set to 100. Bars represent the
t was used to compare β-amyloid-treated or NCS-treated p19 sense or antisense stable
tant samples at 24 h (**p b 0.02; ***p b 0.01, at least). (D) Hippocampal neurons were
4 h later, incubated with 10 μM β-amyloid peptide or 50 ng/ml neocarzinostatin. Immedi-
as percentage of caspase-3 activity with respect to basal activity of cell lysates transfected
hich was set to 100. Bars represent the mean ± S.D. of three independent experiments
with Scr transfectant samples at time point 24 h (*p b 0.05; **p b 0.02). (E) Differentiated
g 16 h. After this time, cells were treated with 50 ng/ml neocarzinostatin. At the indicated
f cell viability with respect to viability of p19AS cells without ZnSO4 treatmentmeasured at
periments performed in sextuplicate. Student's t-test was used to compare ZnSO4 treated
neurons were transfected with p19 antisense oligonucleotide (p19AS) or its scrambled
carzinostatin (G). At the indicated times, cell viability was assessed by MMT reduction
sfected with scrambled oligonucleotide measured at time point zero day, which was set
plicate. Student's t-test was used to compare p19AS transfected samples and scrambled
ssed in SH-SY5Yp19AS clonal cell line during 10 days after neocarzinostatin treatment.
ntiﬁcation of viable colonies. Results are expressed at percentage of viable colonies with
f three independent experiments performed in sextuplicate. Student's t-test was used to
(NCS).
Fig. 6. p19 deﬁciencymake hippocampal cells more sensitive to genotoxic stress. (A) The ﬁgure shows a representative image of the area affected by ODNs and NCS (40×magniﬁcation).
(B) Cannulated mice were injected with p19ASODN in the dorsal hippocampus and with ScrODN in the contra lateral dorsal hippocampus. Sixteen hours later, mice were injected with
25ng/mlNCS or vehicle (saline) in both hippocampi. The presence of γH2AXwas analyzed in coronal sections 24h after injections by immunoﬂuorescence. Nuclei were stainedwith DAPI
(100× magniﬁcation — scale bar: 250 μm, upper panels; 400× magniﬁcation — scale bar: 10 μm, lower panels). (C) Scatter plot showing the percentage of γH2AX-positive cells in
hippocampus slices of ScrODN+ Sal (n= 41 slices), p19ASODN+ Sal (n= 21 slices), ScrODN+NCS (n= 57 slices), and p19ASODN+NCS (48 slices)mice. One way ANOVA indicates
signiﬁcant differences by the treatment (F3,163 = 386.5, p b 0.0001). Bonferroni post hoc comparisons show signiﬁcant differences between treatments (*p b 0.05, ***p b 0.001).
Scrambled (Scr), oligodeoxynucleotide (ODN), saline (Sal), and neocarzinostatin (NCS).
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tional induction and the increased degradation produced by the activa-
tion of calpain.
Aberrant cell cycle activity and DNA damage are emerging as
important pathological components in various neurodegenerative
conditions. Unlike proliferating cells, in which DNA damage typically
triggers cell-cycle checkpoints, postmitotic neurons activate their cell
cycle machinery, under stress conditions, including genotoxic stimula-
tion [53]. This cell cycle re-entry bypostmitotic neurons leads toneuronal
death; inhibition of such ectopic cell cycle activity protects neurons [54].
Previous work demonstrated that the CDK inhibitors p19 and p27Kip1
are rate limiting for neuronal terminal differentiation and suggested
that they are integral components of the molecular machinery that
keeps postmitotic neurons from re-entering the cell cycle after they
migrate to their ﬁnal position [55]. Here, we showed that during the
differentiation process triggered by ATRA in human neuroblastoma
cells, p19 expression was increased in an Egr-1 dependent manner.
Egr-1, an immediate early gene, is a Zn-ﬁnger transcription factor iden-
tiﬁed as a key molecule in the regulation of cell division, differentiation
and apoptosis [56]. It has been reported that Egr-1 displays a functional
role in the process of neuronal death promoted by DNA damage [22].
Egr-1 would induce p35 expression leading to the subsequent CDK5
activation by a mechanism other than calpain-mediated p35-cleavage.
Considering these, and our present results, the high level of p19 in
differentiated neurons would have two related consequences: the
maintenance of the postmitotic state and the protection of neurons
from neurotoxic stimuli.
The results obtained in the cultures of neuronal cells and in the
in vivo experiments underscore the physiological relevance of p19 inthe maintenance of genomic integrity. p19 expression increased the
cellular ability to repair damaged DNA and decreased the genotoxic-
induced apoptosis in neuronal cells. Most importantly, p19 deﬁciency
sensitized hippocampal cells to the genotoxic activity of NCS. The geno-
mic integrity protection provided by p19 seems to have a functional
relevance. Hippocampus-dependent learning and memory tasks were
better preserved from genotoxic damage when p19 expression was
allowed in this brain region.
Based on all the above, we propose a feedbackmechanism bywhich
the neurotoxic effects of CDK5-p25 activated by genotoxic stress or
abnormal intracellular calcium levels are counteracted by the induction
and stabilization of p19 protein reducing the adverse consequences on
the brain functions. Thus, both beneﬁcial and adverse signals can be
triggered by the deregulation of CDK5/p25 activity. The protective effect
exerted byp19would not only be linked to a genotoxic acute damage. In
neurodegenerative disorders such as Alzheimer's disease, Parkinson's
disease and amyotrophic lateral sclerosis, the main risk factor is age
itself [57]. Analysis of postmortem human brain samples has shown
an association between the downregulation of genes encoding for
learning and memory with increased amounts of oxidative damage in
the promoters of the downregulated genes [44]. DNA damage induced
by ROS has the potential to block transcription by RNA polymerase II,
and their accumulation in repair-defective individuals may cause
neuronal cell death, either by progressively depriving the cell of vital
transcripts or through apoptosis [58]. These evidences raise thepossibil-
ity that the accumulation of DNA damage with age could underlie the
pathological changes that are related to neurological disease. In this
scenario, the action of proteins allowing amore robust response against
DNA damage and, in consequence, avoiding excessive apoptosis or
Fig. 7. Impaired hippocampal learning and memory in DNA-damaged p19-deﬁcient mice. Cannulated mice were bilaterally injected with 0.5 μl of 1 ng/ml p19ASODN or ScrODN in the
dorsal hippocampus. Sixteen hours later, mice were injected with 25 ng/ml NCS or vehicle (saline) in both hippocampi. After one week, mice from the three groups were subjected to
the following cognitive tests. (A, B and C)MicePerformance inY-maze device, showingpercentage of (A) correct spontaneous alternations, (B) total distance traveled and (C) total number
of arm entries. (D) Percentage of animals selecting the novel arm as the ﬁrst choice in cued Y-maze. (E) Contextual memory evaluated by the fear conditioning test. The ﬁgure compares
mean values of freezing of the three groups. (F)Micewere tested to the cued fear conditioning, oneday after the contextual test. Freezing responsewasmeasuredduringpre-tone and tone
periods. ScrODN+ Sal (n= 10), ScrODN+ NCS (n= 10) and p19ASODN+ NCS (n= 10). In all cases bars represent the mean ± S.D.
1323M.F. Ogara et al. / Biochimica et Biophysica Acta 1843 (2014) 1309–1324senescence is highly advantageous. The reported ability of p19 in main-
taining genomic integrity would adjust to this premise. Considering
these observations the beneﬁts provided by p19 activation could be
substantial.
Appendix A. Supplementary data
Supplementary data to this article can be found online at http://dx.
doi.org/10.1016/j.bbamcr.2014.03.026.
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